Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Targeted Doxorubicin-Loaded Bacterially Derived Nano-Cells for the Treatment of Neuroblastoma.

Sagnella SM, Trieu J, Brahmbhatt H, MacDiarmid JA, MacMillan A, Whan RM, Fife CM, McCarroll JA, Gifford AJ, Ziegler DS, Kavallaris M.

Mol Cancer Ther. 2018 May;17(5):1012-1023. doi: 10.1158/1535-7163.MCT-17-0738. Epub 2018 Feb 28.

PMID:
29491149
2.

Targeting mesothelin receptors with drug-loaded bacterial nanocells suppresses human mesothelioma tumour growth in mouse xenograft models.

Alfaleh MA, Howard CB, Sedliarou I, Jones ML, Gudhka R, Vanegas N, Weiss J, Suurbach JH, de Bakker CJ, Milne MR, Rumballe BA, MacDiarmid JA, Brahmbhatt H, Mahler SM.

PLoS One. 2017 Oct 23;12(10):e0186137. doi: 10.1371/journal.pone.0186137. eCollection 2017.

3.

Targeted Doxorubicin Delivery to Brain Tumors via Minicells: Proof of Principle Using Dogs with Spontaneously Occurring Tumors as a Model.

MacDiarmid JA, Langova V, Bailey D, Pattison ST, Pattison SL, Christensen N, Armstrong LR, Brahmbhatt VN, Smolarczyk K, Harrison MT, Costa M, Mugridge NB, Sedliarou I, Grimes NA, Kiss DL, Stillman B, Hann CL, Gallia GL, Graham RM, Brahmbhatt H.

PLoS One. 2016 Apr 6;11(4):e0151832. doi: 10.1371/journal.pone.0151832. eCollection 2016.

4.

MicroRNA-7 as a tumor suppressor and novel therapeutic for adrenocortical carcinoma.

Glover AR, Zhao JT, Gill AJ, Weiss J, Mugridge N, Kim E, Feeney AL, Ip JC, Reid G, Clarke S, Soon PS, Robinson BG, Brahmbhatt H, MacDiarmid JA, Sidhu SB.

Oncotarget. 2015 Nov 3;6(34):36675-88. doi: 10.18632/oncotarget.5383.

5.

First in human nanotechnology doxorubicin delivery system to target epidermal growth factor receptors in recurrent glioblastoma.

Whittle JR, Lickliter JD, Gan HK, Scott AM, Simes J, Solomon BJ, MacDiarmid JA, Brahmbhatt H, Rosenthal MA.

J Clin Neurosci. 2015 Dec;22(12):1889-94. doi: 10.1016/j.jocn.2015.06.005. Epub 2015 Aug 13.

PMID:
26279503
6.

Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma.

Reid G, Pel ME, Kirschner MB, Cheng YY, Mugridge N, Weiss J, Williams M, Wright C, Edelman JJ, Vallely MP, McCaughan BC, Klebe S, Brahmbhatt H, MacDiarmid JA, van Zandwijk N.

Ann Oncol. 2013 Dec;24(12):3128-35. doi: 10.1093/annonc/mdt412. Epub 2013 Oct 22.

PMID:
24148817
7.

Minicells: versatile vectors for targeted drug or si/shRNA cancer therapy.

MacDiarmid JA, Brahmbhatt H.

Curr Opin Biotechnol. 2011 Dec;22(6):909-16. doi: 10.1016/j.copbio.2011.04.008. Epub 2011 May 6. Review.

PMID:
21550793
8.

Sequential treatment of drug-resistant tumors with targeted minicells containing siRNA or a cytotoxic drug.

MacDiarmid JA, Amaro-Mugridge NB, Madrid-Weiss J, Sedliarou I, Wetzel S, Kochar K, Brahmbhatt VN, Phillips L, Pattison ST, Petti C, Stillman B, Graham RM, Brahmbhatt H.

Nat Biotechnol. 2009 Jul;27(7):643-51. doi: 10.1038/nbt.1547. Epub 2009 Jun 28.

PMID:
19561595
9.

Bacterially-derived nanocells for tumor-targeted delivery of chemotherapeutics and cell cycle inhibitors.

MacDiarmid JA, Madrid-Weiss J, Amaro-Mugridge NB, Phillips L, Brahmbhatt H.

Cell Cycle. 2007 Sep 1;6(17):2099-105. Epub 2007 Jun 27.

PMID:
17786046
10.

Bacterially derived 400 nm particles for encapsulation and cancer cell targeting of chemotherapeutics.

MacDiarmid JA, Mugridge NB, Weiss JC, Phillips L, Burn AL, Paulin RP, Haasdyk JE, Dickson KA, Brahmbhatt VN, Pattison ST, James AC, Al Bakri G, Straw RC, Stillman B, Graham RM, Brahmbhatt H.

Cancer Cell. 2007 May;11(5):431-45.

11.

Use of a monoclonal antibody to ovine IgE for fly strike studies in sheep.

MacDiarmid JA, Clarke R, McClure SJ, Bowen FR, Burrell DH.

Int J Parasitol. 1995 Dec;25(12):1505-7.

PMID:
8719964
12.

Characterization of Pseudomonas maltophilia Isolates from Fleece Rot.

Macdiarmid JA, Burrell DH.

Appl Environ Microbiol. 1986 Feb;51(2):346-8.

13.

Characterisation of isolates of Pseudomonas aeruginosa from sheep.

Burrell DH, MacDiarmid JA.

Aust Vet J. 1984 Sep;61(9):277-9.

PMID:
6440524

Supplemental Content

Loading ...
Support Center